Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Losa, F; Iglesias, L; Pane, M; Sanz, J; Nieto, B; Fuste, V; de la Cruz-Merino, L; Concha, A; Balañá C; Matias-Guiu, X

    2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary

    CLINICAL & TRANSLATIONAL ONCOLOGY 20 1361-1372. .

    [doi:10.1007/s12094-018-1899-z]

  • Versluis, MAC; Plat, A; de Bruyn, M; Matias-Guiu, X; Trovic, J; Krakstad, C; Nijman, HW; Bosse, T; de Bock, GH; Hollema, H

    L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition

    VIRCHOWS ARCHIV 473 591-598. .

    [doi:10.1007/s00428-018-2444-8]

  • Moiola, CP; Lopez-Gil, C; Cabrera, S; Garcia, A; Van Nyen, Tom; Annibali, D; Fonnes, T; Vidal, A; Villanueva, A; Matias-Guiu, X; Krakstad, C; Amant, F; Gil-Moreno, A; Colas, E

    Patient-Derived Xenograft Models for Endometrial Cancer Research

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 19 -. .

    [doi:10.3390/ijms19082431]

  • Maiques, O; Barcelo, C; Panosa, A; Pijuan, J; Orgaz, JL; Rodriguez-Hernandez, I; Matas-Nadal, C; Tell, G; Vilella, R; Fabra, A; S P; Sanz-Moreno, V; Matias-Guiu, X; Canti, C; Herreros, J; Marti, RM; Macia, A

    T-type calcium channels drive migration/invasion in BRAFV600E melanoma cells through Snail1

    PIGMENT CELL & MELANOMA RESEARCH 31 484-495. .

    [doi:10.1111/pcmr.12690]

  • Garrido, Pilar; Aldaz, Azucena; Calleja, Miguel Angel; de Alava, Enrique; Lamas, Maria Jesus; Martin, Miguel; Matias-Guiu, Xavier; Palacios, Jose; Vera, Ruth

    Propuesta para la creación de una Estrategia Nacional sobre Medicina de Precisión en Cáncer: posicionamiento de la SEOM, SEAP y SEFH.

    Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 51 154-159. .

    [doi:10.1016/j.patol.2017.10.003]

  • Capdevila, J; Mayor, R; Mancuso, FM; Iglesias, C; Caratu, G; Matos, I; Zafon, C; Hernando, J; Petit, A; Nuciforo, P; Cameselle-Teijeiro, JM; Alvarez, C; Recio, JA; Tabernero, J; Matias-Guiu, X; Vivancos, A; Seoane, J

    Early evolutionary divergence between papillary and anaplastic thyroid cancers

    ANNALS OF ONCOLOGY 29 1454-1460. .

    [doi:10.1093/annonc/mdy123]

  • Goebel, EA; Vidal, A; Matias-Guiu, X; Blake Gilks C

    The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future

    VIRCHOWS ARCHIV 472 885-896. .

    [doi:10.1007/s00428-017-2279-8]

  • Bosse, T; Nout, RA; McAlpine, JN; McConechy, MK; Britton, H; Hussein, YR; Gonzalez, C; Ganesan, R; Steele, JC; Harrison, BT; Oliva, E; Vidal, A; Matias-Guiu, X; Abu-Rustum, NR; Levine, DA; Gilks, CB; Soslow, RA

    Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 42 561-568. .

    [doi:10.1097/PAS.0000000000001020]

  • Alsina-Sanchis, E; Garcia-Ibanez, Y; Figueiredo, AM; Riera-Domingo, C; Figueras, A; Matias-Guiu, X; Casanovas, O; Botella, LM; Pujana, MA; Riera-Mestre, A; Graupera, M; Viñals F

    ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 38 1216-1229. .

    [doi:10.1161/ATVBAHA.118.310760]

  • Garrido, P; Aldaz, A; Vera, R; Calleja, MA; de Alava, E; Martin, M; Matias-Guiu, X; Palacios, J

    Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH

    CLINICAL & TRANSLATIONAL ONCOLOGY 20 443-447. .

    [doi:10.1007/s12094-017-1740-0]

  • Zhu, C; Farre, G; Zanga, D; Lloveras, J; Michelena, A; Ferrio, JP; Voltas, J; Slafer, G; Savin, R; Albajes, R; Eizaguirre, M; Lopez, C; Cantero-Martinez, C; Diaz-Gomez, J; Nogareda, C; Moreno, JA; Angulo, E; Estany, J; Pena, RN; Tor, M; Portero-Otin, M; Eritja, N; Arjo, G; Serrano, JCE; Matias-Guiu, X; Twyman, RM; Sandmann, G; Capell, T; Christou, P

    High-carotenoid maize: development of plant biotechnology prototypes for human and animal health and nutrition

    PHYTOCHEMISTRY REVIEWS 17 195-209. .

    [doi:10.1007/s11101-017-9506-4]

  • Cuppens, T; Moisse, M; Depreeuw, J; Annibali, D; Colas, E; Gil-Moreno, A; Huvila, J; Carpen, O; Zikan, M; Matias-Guiu, X; Moerman, P; Croce, S; Lambrechts, D; Amant, F

    Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways

    INTERNATIONAL JOURNAL OF CANCER 142 1230-1243. .

    [doi:10.1002/ijc.31129]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment